The_Right_Honourable_Brit
High Tory
- Joined
- Mar 6, 2004
- Messages
- 41,699
Exclusive: US biotech group to trial Covid-19 pill for use at home
A US biotech company is to start trialling a coronavirus pill on patients who test positive for Covid-19 but do not require hospitalisation, in one of the first experiments of its kind.
Ridgeback Biotherapeutics told the Financial Times that the drug, codenamed EIDD-2801, had cleared phase one safety trials and that the company would now start recruiting patients for the next stage of testing to determine whether it could fight the virus.
The trial is one of the first studies of a pill that could be prescribed not only to very sick hospitalised patients but also to those who test positive and are well enough to quarantine at home.
If the drug is ultimately successful, it would offer a simple twice-a-day tablet that could be given to millions of patients who test positive, preventing them from becoming seriously ill and helping them recover more quickly.
The trial comes as drugmakers rush to research potential treatments and vaccines for the virus, which has killed more than 450,000 people worldwide, according to Johns Hopkins University.
www.ft.com
Although this company sounds sketchy: https://www.sciencemag.org/news/202...arges-cronyism-behind-potential-covid-19-drug
A US biotech company is to start trialling a coronavirus pill on patients who test positive for Covid-19 but do not require hospitalisation, in one of the first experiments of its kind.
Ridgeback Biotherapeutics told the Financial Times that the drug, codenamed EIDD-2801, had cleared phase one safety trials and that the company would now start recruiting patients for the next stage of testing to determine whether it could fight the virus.
The trial is one of the first studies of a pill that could be prescribed not only to very sick hospitalised patients but also to those who test positive and are well enough to quarantine at home.
If the drug is ultimately successful, it would offer a simple twice-a-day tablet that could be given to millions of patients who test positive, preventing them from becoming seriously ill and helping them recover more quickly.
The trial comes as drugmakers rush to research potential treatments and vaccines for the virus, which has killed more than 450,000 people worldwide, according to Johns Hopkins University.
Subscribe to read | Financial Times
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Although this company sounds sketchy: https://www.sciencemag.org/news/202...arges-cronyism-behind-potential-covid-19-drug


